FDA Inspection 804154 — Antares Pharma Inc.
The FDA completed an inspection of Antares Pharma Inc. on August 20, 2012 in Ewing, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 20, 2012
- Fiscal Year
- 2012
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Ewing, NJ (United States)